Valued Wealth Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1K Sell
236
-14
-6% -$760 ﹤0.01% 307
2026
Q1
$15.7K Buy
250
+13
+5% +$1.04K 0.01% 214
2025
Q4
$22.6K Buy
237
+4
+2% +$392 0.01% 147
2025
Q3
$22.7K Buy
233
+1
+0.4% +$104 0.01% 138
2025
Q2
$24.9K Hold
232
0.01% 131
2025
Q1
$23.4K Hold
232
0.01% 141
2024
Q4
$20.7K Sell
232
-6
-3% -$528 0.01% 156
2024
Q3
$19.9K Sell
238
-1,301
-85% -$103K 0.01% 148
2024
Q2
$119K Hold
1,539
0.08% 43
2024
Q1
$105K Sell
1,539
-1
-0.1% -$64 0.07% 40
2023
Q4
$81.3K Buy
+1,540
New +$82.2K 0.08% 36

Other funds holding BSX

Valued Wealth Advisors's BSX Position: Q2 2026 in Review

Valued Wealth Advisors reduced its Boston Scientific (BSX) stake by 5.6% in Q2 2026, selling an estimated $760 and leaving 236 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #307.

Valued Wealth Advisors first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $119K in Q2 2024. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Valued Wealth Advisors held 236 shares of Boston Scientific worth $10.1K as of Q2 2026.
  • Valued Wealth Advisors sold 14 Boston Scientific shares in Q2 2026, an estimated $760.
  • Boston Scientific made up ﹤0.01% of Valued Wealth Advisors's portfolio in Q2 2026, its #307 holding.
  • Valued Wealth Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Valued Wealth Advisors's Boston Scientific position peaked at $119K in Q2 2024.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.